Transforming growth factor-β transiently induces vimentin expression and invasive capacity in a canine mammary gland tumor cell line

Research in Veterinary Science

Volumn 94, Issue 3, 2013, Pages 539-541

  Yoshida, K ^a   Saito, T ^a   Kamida, A ^a   Matsumoto, K ^a   Saeki, K ^a   Mochizuki, M ^a   Sasaki, N ^a   Nakagawa, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Dog; EMT; Mammary gland tumor; MET; TGF ; XCELLigence RTCA

Indexed keywords

RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL INVASION; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; DISEASE ACTIVITY; DOG; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; MESENCHYME; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TREATMENT RESPONSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DOG DISEASES; DOGS; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM INVASIVENESS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

CANIS FAMILIARIS;

EID: 84876101655     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.10.016     Document Type: Article

References (23)

1. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research 1987, 47:3239-3245.
2. Aomatsu K., Arao T., Sugioka K., Matsumoto K., Tamura D., Kudo K., Kaneda H., Tanaka K., Fujita Y., Shimomura Y., Nishio K. TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line. Investigative Ophthalmology & Visual Science 2011, 14:2437-2443.
3. Brodey R.S., Goldschmidt M.H., Roszel J.R. Canine mammary gland neoplasms. Journal of the American Animal Hospital Association 1983, 19:61-90.
4. Brown K.A., Aakre M.E., Gorska A.E., Price J.O., Eltom S.E., Pietenpol J.A., Moses H.L. Induction by transforming growth factor-beta 1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Research 2004, 6:R215-231.
5. Gilbertson S.R., Kurzman I.D., Zachrau R.E., Hurvitz A.I., Black M.M. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 1983, 20:127-142.
6. Hamada J., Nagayasu H., Kawano T., Mizutani T., Nakata D., Hosokawa M., Takeichi N. Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body. Clinical & Experimental Metastasis 1998, 16:291-298.
7. Heldin C.H., Moustakas A. Role of Smads in TGFβ signaling. Cell and Tissue Research 2012, 347:21-36.
8. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D., Thompson E.W. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Journal of Cellular Physiology 2007, 213:374-383.
9. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation 2009, 119:1420-1428.
10. Kokkinos M.I., Wafai R., Wong M.K., Newgreen D.F., Thompson E.W., Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer - observations in vitro and in vivo. Cells Tissues Organs 2007, 185:191-203.
11. Lenferink A.E., Magoon J., Cantin C., O'Connor-McCourt M.D. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition. Breast Cancer Research 2004, 6:R514-530.
12. Matos A.J.F., Lopes C., Carvalheira J., Santos M., Rutteman G.R., Gärtner F. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. Journal of Comparative Pathology 2006, 134:182-189.
13. Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. Journal of Cell Biology 1994, 127:2021-2036.
14. Misdorp W., Hart A.A.M. Canine mammary cancer. II. Therapy and causes of death. Journal of Small Animal Practice 1979, 20:395-404.
15. Moustakas A., Heldin C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Science 2007, 98:1512-1520.
16. Rodo A., Malicka E. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches. Polish Journal of Veterinary Sciences 2008, 11:47-54.
17. Sarli G., Preziosi R., Tolla L.D., Brunetti B., Benazzi C. E-cadherin immunoreactivity in canine mammary tumors. Journal of Veterinary Diagnostic Investigation 2004, 16:542-547.
18. Shi Y., Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
19. Thiery J.P. Epithelial-mesenchymal transition in tumour progression. Nature Reviews Cancer 2002, 2:442-454.
20. Tsuji T., Ibaragi S., Hu G. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Research 2009, 15:7135-7139.
21. Xu J., Lamouille S., Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Research 2009, 19:156-172.
22. Yao D., Dai C., Peng S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Molecular Cancer Research 2011, 9:1608-1620.
23. Zavadil J., Böttinger E.P. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.